Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 38851-38900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05938881
Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study
N/ARecruiting
336 participants
Started: Jun 29, 2023 · Completed: Mar 12, 2033
1 condition1 sponsor11 locations
NCT05779852
Pain Management of Amputation Wounds With AutoHypnosis
NARecruiting
44 participants
Started: Jun 29, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05726981
Ultrasound and Cytological Evaluation 3 Years After Radiofrequency Thermal Ablation of Benign Thyroid Nodules : a Prospective Exploratory Cohort of 180 Nodules
NARecruiting
180 participants
Started: Jun 29, 2023 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05662228
Therapies for Down Syndrome Regression Disorder
PHASE2Recruiting
66 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT05894018
Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma
PHASE2Recruiting
32 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05868876
A Phase Ia/Ib Open Label,Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
PHASE1Recruiting
205 participants
Started: Jun 29, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT05686278
Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
N/ARecruiting
368 participants
Started: Jun 29, 2023 · Completed: Sep 30, 2033
5 conditions1 sponsor3 locations
NCT05940896
RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression
PHASE1Recruiting
24 participants
Started: Jun 29, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT05332561
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
PHASE2Recruiting
240 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor9 locations
NCT06691971
AeviceMD for Detection of Wheeze in Pediatric and Adult Populations
N/ARecruiting
160 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2026
6 conditions2 sponsors1 location
NCT06083363
Longitudinal Recovery Trajectories After an Acute Respiratory Distress Syndrome, a New Understanding
N/ARecruiting
246 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors3 locations
NCT05706766
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NARecruiting
30 participants
Started: Jun 29, 2023 · Completed: Jul 31, 2026
2 conditions1 sponsor2 locations
NCT05655936
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
NARecruiting
454 participants
Started: Jun 29, 2023 · Completed: Jul 1, 2027
14 conditions2 sponsors1 location
NCT05954858
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NARecruiting
32 participants
Started: Jun 29, 2023 · Completed: Jun 30, 2027
7 conditions1 sponsor1 location
NCT05136976
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
PHASE3Recruiting
90 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors15 locations
NCT05425264
Home-Based Exercise Tele-Rehabilitation After COVID-19
NARecruiting
80 participants
Started: Jun 29, 2023 · Completed: Jan 30, 2028
1 condition3 sponsors1 location
NCT06225180
Review of Breast Abscess Management
N/ARecruiting
500 participants
Started: Jun 29, 2023 · Completed: Jun 29, 2024
1 condition1 sponsor2 locations
NCT05678764
Evaluation of a Conversational Information Collection Tool to Access Talk Therapy
N/ARecruiting
300,000 participants
Started: Jun 29, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05962840
Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)
PHASE4Recruiting
40 participants
Started: Jun 29, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06138457
The ECOSTRESS Study: Influence of the Objective Structured Clinical Examination on Stress Among Medical Student
N/ARecruiting
100 participants
Started: Jun 29, 2023 · Completed: Jun 29, 2030
3 conditions1 sponsor2 locations
NCT05937841
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
EARLY_PHASE1Recruiting
30 participants
Started: Jun 28, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05534243
The ED-AWARENESS-2 Trial
NARecruiting
3,090 participants
Started: Jun 28, 2023 · Completed: Sep 1, 2027
4 conditions2 sponsors4 locations
NCT06490887
Spine Unit Modelling Coupled With hIgh Throughput Analysis (SUIT)
N/ARecruiting
20 participants
Started: Jun 28, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT05691270
Contraception Navigator Program
NARecruiting
50 participants
Started: Jun 28, 2023 · Completed: Sep 1, 2026
3 conditions2 sponsors1 location
NCT05787821
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
N/ARecruiting
760 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2035
9 conditions1 sponsor16 locations
NCT05813236
NOVOSYN® Quick Versus MONOSYN® Quick Suture Material in Resective Periodontal Surgery
NARecruiting
84 participants
Started: Jun 28, 2023 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT06034912
Fundus Effects of Repeated Low-Level Red-Light Therapy in Chinese Myopic Minors: A Randomized Controlled Clinical Trial
NARecruiting
70 participants
Started: Jun 28, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05155163
Stepped Care for Patients to Optimize Whole Recovery
NARecruiting
204 participants
Started: Jun 28, 2023 · Completed: Aug 31, 2026
2 conditions2 sponsors2 locations
NCT05810402
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
NARecruiting
60 participants
Started: Jun 28, 2023 · Completed: May 31, 2027
5 conditions1 sponsor1 location
NCT05783466
Dairy Lipids and Cardiometabolic Risk
NARecruiting
75 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2026
1 condition4 sponsors2 locations
NCT05766774
FEED-Cystic Fibrosis (FEED-CF)
NARecruiting
60 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2028
2 conditions2 sponsors1 location
NCT05785754
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
PHASE1Recruiting
320 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor35 locations
NCT05913804
YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
12 participants
Started: Jun 28, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository
N/ARecruiting
3,500 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2035
3 conditions1 sponsor21 locations
NCT05671510
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
PHASE3Recruiting
600 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors160 locations
NCT06699446
"The Seamless Patient:From Preoperative Preparation to Postoperative Rehabilitation"
NARecruiting
300 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05878769
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
PHASE3Recruiting
2,000 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor462 locations
NCT06345820
Comparison of Two Non-diffractive Enhanced Monofocal Intraocular Lenses
NARecruiting
35 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05999448
Promoting the Well Being of Caregivers Via Telehealth
NARecruiting
800 participants
Started: Jun 28, 2023 · Completed: Dec 29, 2025
2 conditions7 sponsors1 location
NCT05396248
Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
NARecruiting
120 participants
Started: Jun 28, 2023 · Completed: Mar 31, 2027
1 condition3 sponsors2 locations
NCT05672550
Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)
PHASE4Recruiting
50 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2026
1 condition1 sponsor18 locations
NCT05661643
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
PHASE2Recruiting
29 participants
Started: Jun 28, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05701241
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
PHASE4Recruiting
270 participants
Started: Jun 28, 2023 · Completed: Apr 30, 2034
1 condition4 sponsors19 locations
NCT06516445
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
PHASE2Recruiting
33 participants
Started: Jun 28, 2023 · Completed: Jun 28, 2026
1 condition1 sponsor1 location
NCT05725096
Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population
NARecruiting
3,400 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2027
4 conditions1 sponsor1 location
NCT06016946
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
N/ARecruiting
3,000 participants
Started: Jun 28, 2023 · Completed: Jan 28, 2048
1 condition1 sponsor34 locations
NCT06018636
Impact of Diet and Nutrition on Growth and Development in Young Children
N/ARecruiting
832 participants
Started: Jun 28, 2023 · Completed: Sep 30, 2028
7 conditions4 sponsors1 location
NCT06028555
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
N/ARecruiting
101,000 participants
Started: Jun 28, 2023 · Completed: Oct 31, 2028
2 conditions3 sponsors1 location
NCT05945433
Anovo™ Surgical System - Registry Study
N/ARecruiting
300 participants
Started: Jun 28, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05806099
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
PHASE1/PHASE2Recruiting
132 participants
Started: Jun 28, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location